Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.2.0.727
Consolidated Statements of Cash Flows - Entity [Domain] - USD ($)
 9 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net Loss $ (1,850,066) $ (8,777,837)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation Expense 0 322
Stock-based compensation 859,627 748,600
Noncash interest expense on notes payable 212,332 83,295
Issuance of common stock for services 8,625 77,625
Gain on exercise of warrants (299,321) 0
Loss on warrant derivative modification, net of inducement shares 996,813 0
Decrease to fair value of derivative (2,924,064) (2,069,693)
Non cash expense for issuance of warrants 0 7,541,693
Other noncash adjustments 0 92,500
(Increase) decrease in:    
Prepaid expenses and other current assets (621) (2,515)
Increase (decrease) in:    
Accounts payable 323,850 (148,758)
Accrued expenses and other liabilities 46,069 75,270
Net cash used in operating activities (2,626,756) (2,379,498)
Cash flows from financing activities:    
Proceeds from exercise of warrants 1,251,000 0
Proceeds from issuance of common stock and warrants 3,066,000 2,624,703
Proceeds from issuance of convertible notes 750,000 0
Proceeds from issuance of notes payable 0 1,000,000
Net cash provided by financing activities 5,067,000 3,624,703
Net incerease in cash and cash equivalents 2,440,244 1,245,205
Cash and cash equivalents, beginning of period 833,520 557,319
Cash and cash equivalents, end of period 3,273,764 1,802,524
Non-cash financing activities    
Issuance of Inducement shares $ 100,050 $ 0